New FDA draft guidance outlines reduced reliance on primates for monoclonal antibody toxicity testing, aiming to lower costs and accelerate drug development.
WHO’s first guideline on GLP-1 therapies warns that weight-loss drugs alone won’t solve obesity, urging comprehensive care, healthy habits, and safer access policies